| FBTAX | RYBOX | FBTAX / RYBOX | |
| Total Expense Ratio | 0.96 | 1.64 | 59% |
| Annual Report Gross Expense Ratio | 0.96 | 1.69 | 57% |
| Fund Existence | 26 years | 22 years | - |
| Gain YTD | 22.730 | 17.579 | 129% |
| Front Load | 6% | 5% | 121% |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.2B | 124M | 1,776% |
| Annual Yield % from dividends | 0.98 | 0.00 | - |
| Returns for 1 year | 66.65 | 28.92 | 230% |
| Returns for 3 years | 90.91 | 21.11 | 431% |
| Returns for 5 years | 49.01 | -20.42 | -240% |
| Returns for 10 years | 125.12 | -1.20 | -10,444% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TPRY | 18.06 | 0.68 | +3.89% |
| VistaShares Target 15 TEPRTntmConDisETF | |||
| XB | 38.95 | 0.16 | +0.40% |
| BondBloxx B Rated USD Hi Yld Corp Bd ETF | |||
| DFGP | 53.44 | 0.12 | +0.23% |
| Dimensional Global Core Pls Fxd Inc ETF | |||
| CAFX | 24.45 | N/A | +0.02% |
| Congress Intermediate Bond ETF | |||
| BBH | 208.01 | -0.63 | -0.30% |
| VanEck Biotech ETF | |||